We are live on
!
Find out more
Plus Therapeutics
PSTV
PSTV
8 hedge funds and large institutions have $718K invested in Plus Therapeutics in 2021 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 5 increasing their positions, 0 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
0.01% less ownership
Funds ownership: 0.02% → 0.01% (-0.01%)
7% less capital invested
Capital invested by funds: $768K → $718K (-$50K)
20% less funds holding
Funds holding: 10 → 8 (-2)
50% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 4
Holders
8
Holders Change
-2
Holders Change %
-20%
% of All Funds
0.14%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
5
Reduced
–
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$151K |
| 2 |
Two Sigma Advisers
New York
|
+$98.3K |
| 3 |
BRWM
B. Riley Wealth Management
Memphis,
Tennessee
|
+$32.4K |
| 4 |
Creative Planning
Overland Park,
Kansas
|
+$7.1K |
| 5 |
Osaic Holdings
Scottsdale,
Arizona
|
+$5.07K |
Top Sellers
| 1 |
Renaissance Technologies
New York
|
-$214K |
| 2 |
Two Sigma Investments
New York
|
-$114K |
| 3 |
VF
Virtu Financial
New York
|
-$37K |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$25K |